Is Saccharomyces boulardii registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 2 valid registrations of Saccharomyces boulardii, including FLORATIL (100 mg, Powder for oral suspension, SAR 26.25); FLORATIL (200 mg, Capsule, hard, SAR 59.90).

Active substance

Saccharomyces boulardii

SFDA 2

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
FLORATIL	100 mg	Powder for oral suspension · Oral use	20 Sachet	SAR 26.25	NCE · Prescription	Biocodex	Valid
FLORATIL	200 mg	Capsule, hard · Oral use	30 Bottle	SAR 59.90	NCE · Prescription	Biocodex	Valid

Indications — CHI Daman Drug Formulary

DIARRHEA

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.